Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gower Publishing

- PMLiVE

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality

How pharma is progressing their commitment in patient engagement

- PMLiVE

Q&A: Niels Lund

PME interviews Novo Nordisk's Vice President, Health Advocacy

- PMLiVE

Novartis makes case for gene therapy Zolgensma in SMA

New data revealed ahead of FDA review

- PMLiVE

Adding different perspectives to scientific communications at Porterhouse Medical

Porterhouse Medical Group is delighted to announce that, once again, we have strengthened our scientific services team – this time with three new associate medical writers who, with different scientific...

Porterhouse Medical Group

- PMLiVE

Stem cell transplant firms Kiadis and CytoSen join forces

Acquires an NK cell based platform with the deal

Roche Basel Switzerland

Hemlibra off to a flyer as Roche raises 2019 forecasts

Drug has made almost as much in this quarter as it did in 2018

- PMLiVE

Gilead drives NASH development with insitro collaboration

Announcement comes days after Novo Nordisk deal

- PMLiVE

Akcea steals march on Alnylam with NICE approval

Advantage to Tegsedi over Onpattro

- PMLiVE

Catalent preps for complex therapy boom with $1.2bn Paragon buy

Reflects growing investment in cell and gene therapies

- PMLiVE

First-in-class hepatitis B/D drug raises cure hope

Those taking the regimen saw virus levels decline

- PMLiVE

Chi-Med goes for third IPO in Hong Kong

New listing follows first product launch

Cuttsy+Cuttsy awarded IPA Platinum

Cuttsy+Cuttsy awarded CPD Platinum by the IPA

Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation.

Cuttsy + Cuttsy

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links